Dr. Melissa Crampsie is Vice President of Oncology at SAI MedPartners and has helped create and lead the Oncology Business Unit at SAI. Since joining the company in 2013, Dr. Crampsie has led dozens of oncology-focused projects for both solid and liquid tumors from new product planning to late-stage commercial/LCM support and continues to manage projects. Additionally, Dr. Crampsie has oversight on project staffing, operations, training, and coordinating attendance for the major Oncology medical conferences each year. The goal of the Oncology Business Unit is to provide deep therapy area expertise and to function as a thought partner for clients.

Prior to consulting, Dr. Crampsie worked in the pharmaceutical/biotech sector in both R&D and manufacturing. Former companies include BioSample Solutions, a start-up focused on novel nucleic acid extraction technology for diagnostic applications, and Centocor (now a part of Janssen) in R&D and manufacturing of anti-TNFα antibodies.

Dr. Crampsie earned a PhD in pharmacology and an MBA from Penn State University. In addition, she has a dual BS in pharmaceutical product development and cell and molecular biology from West Chester University.